306 related articles for article (PubMed ID: 8922748)
1. Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):976-84. PubMed ID: 8922748
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites.
Cox SL; Ben A; Story DF; Ziogas J
Br J Pharmacol; 1995 Mar; 114(5):1057-63. PubMed ID: 7780640
[TBL] [Abstract][Full Text] [Related]
4. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the renin-angiotensin system, bradykinin and sympathetic nerves with cholinergic transmission in the rat isolated trachea.
Fabiani ME; Dinh DT; Story DF
Br J Pharmacol; 1997 Nov; 122(6):1089-98. PubMed ID: 9401774
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-induced enhancement of excitatory junction potentials evoked by periarteriolar nerve stimulation and vasoconstriction in rat mesenteric arteries are both mediated by the angiotensin AT1 receptor.
Ziogas J; Vessey K
Pharmacology; 2001; 63(2):103-11. PubMed ID: 11490203
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery.
Vo PA; Reid JJ; Rand MJ
Br J Pharmacol; 1992 Dec; 107(4):1121-8. PubMed ID: 1467834
[TBL] [Abstract][Full Text] [Related]
8. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.
Bucher B; Ouedraogo S; Tschöpl M; Paya D; Stoclet JC
Br J Pharmacol; 1992 Dec; 107(4):976-82. PubMed ID: 1334757
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
[TBL] [Abstract][Full Text] [Related]
10. Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.
Ruiz-Gayo M; Somoza B; Bravo R; Fernández-Alfonso MS; González C
Life Sci; 2000 Nov; 67(26):3153-62. PubMed ID: 11191622
[TBL] [Abstract][Full Text] [Related]
11. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
[TBL] [Abstract][Full Text] [Related]
12. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
[TBL] [Abstract][Full Text] [Related]
13. Analysis of responses to ANG IV: effects of PD-123319 and DuP-753 in the pulmonary circulation of the rat.
Nossaman BD; Feng CJ; Kaye AD; Kadowitz PJ
Am J Physiol; 1995 Feb; 268(2 Pt 1):L302-8. PubMed ID: 7864150
[TBL] [Abstract][Full Text] [Related]
14. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.
Shetty SS; DelGrande D
J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310
[TBL] [Abstract][Full Text] [Related]
16. Segmental differences in angiotensin receptor subtypes in interlobular artery of hydronephrotic rat kidneys.
Hayashi K; Suzuki H; Saruta T
Am J Physiol; 1993 Dec; 265(6 Pt 2):F881-5. PubMed ID: 8285220
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
18. AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission.
Rodriguez-Campos M; Kadarian C; Rodano V; Bianciotti L; Fernandez B; Vatta M
Cell Mol Neurobiol; 2000 Dec; 20(6):747-62. PubMed ID: 11100981
[TBL] [Abstract][Full Text] [Related]
19. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
[TBL] [Abstract][Full Text] [Related]
20. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Li Q; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
